Molina Healthcare (NYSE:MOH) Lifted to Strong-Buy at StockNews.com

StockNews.com upgraded shares of Molina Healthcare (NYSE:MOH) from a buy rating to a strong-buy rating in a research note released on Friday.

MOH has been the subject of a number of other research reports. Cantor Fitzgerald reiterated an overweight rating and issued a $359.00 price target on shares of Molina Healthcare in a research note on Thursday, September 14th. UBS Group initiated coverage on shares of Molina Healthcare in a research report on Tuesday, June 20th. They set a neutral rating and a $310.00 price objective for the company. Morgan Stanley restated an overweight rating and set a $365.00 price objective on shares of Molina Healthcare in a research report on Friday, July 14th. Truist Financial reduced their price objective on shares of Molina Healthcare from $380.00 to $365.00 in a research report on Tuesday, June 20th. Finally, Bank of America boosted their price objective on shares of Molina Healthcare from $340.00 to $350.00 in a research report on Thursday, July 27th. One research analyst has rated the stock with a sell rating, four have issued a hold rating, six have given a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of Moderate Buy and a consensus target price of $351.31.

Molina Healthcare Stock Up 0.4 %

Shares of Molina Healthcare stock opened at $329.00 on Friday. Molina Healthcare has a 52-week low of $256.19 and a 52-week high of $374.00. The company has a 50 day moving average of $312.91 and a 200 day moving average of $293.71. The company has a quick ratio of 1.52, a current ratio of 1.52 and a debt-to-equity ratio of 0.66. The company has a market capitalization of $19.18 billion, a P/E ratio of 20.85, a P/E/G ratio of 1.11 and a beta of 0.65.

Molina Healthcare (NYSE:MOH) last issued its quarterly earnings results on Wednesday, July 26th. The company reported $5.65 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $5.05 by $0.60. Molina Healthcare had a net margin of 2.81% and a return on equity of 35.87%. The company had revenue of $8.33 billion during the quarter, compared to the consensus estimate of $8.32 billion. During the same quarter in the previous year, the firm earned $4.55 earnings per share. The firm’s quarterly revenue was up 3.4% on a year-over-year basis. As a group, research analysts forecast that Molina Healthcare will post 20.78 EPS for the current fiscal year.

Insider Activity at Molina Healthcare

In related news, Director Steven J. Orlando sold 723 shares of the company’s stock in a transaction on Friday, August 4th. The shares were sold at an average price of $301.25, for a total value of $217,803.75. Following the completion of the sale, the director now owns 20,265 shares in the company, valued at approximately $6,104,831.25. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In related news, Director Steven J. Orlando sold 723 shares of the company’s stock in a transaction on Friday, August 4th. The shares were sold at an average price of $301.25, for a total value of $217,803.75. Following the completion of the sale, the director now owns 20,265 shares in the company, valued at approximately $6,104,831.25. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, insider Jeff D. Barlow sold 12,500 shares of the business’s stock in a transaction on Tuesday, August 1st. The shares were sold at an average price of $302.77, for a total transaction of $3,784,625.00. Following the completion of the transaction, the insider now directly owns 64,973 shares in the company, valued at $19,671,875.21. The disclosure for this sale can be found here. Insiders sold a total of 17,938 shares of company stock worth $5,474,336 in the last 90 days. 1.10% of the stock is owned by insiders.

Hedge Funds Weigh In On Molina Healthcare

Institutional investors have recently bought and sold shares of the company. Vanguard Group Inc. grew its stake in shares of Molina Healthcare by 18.4% during the 1st quarter. Vanguard Group Inc. now owns 6,449,375 shares of the company’s stock worth $2,151,448,000 after purchasing an additional 1,001,372 shares during the period. BlackRock Inc. grew its stake in shares of Molina Healthcare by 2.4% during the 2nd quarter. BlackRock Inc. now owns 4,865,464 shares of the company’s stock worth $1,465,672,000 after purchasing an additional 113,511 shares during the period. Capital World Investors grew its stake in shares of Molina Healthcare by 1.2% during the 2nd quarter. Capital World Investors now owns 4,352,122 shares of the company’s stock worth $1,311,033,000 after purchasing an additional 53,139 shares during the period. Price T Rowe Associates Inc. MD grew its stake in shares of Molina Healthcare by 59.5% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 3,787,368 shares of the company’s stock worth $1,013,084,000 after purchasing an additional 1,413,257 shares during the period. Finally, Wellington Management Group LLP grew its stake in shares of Molina Healthcare by 40.4% during the 1st quarter. Wellington Management Group LLP now owns 2,603,321 shares of the company’s stock worth $696,362,000 after purchasing an additional 749,696 shares during the period. 98.11% of the stock is owned by institutional investors and hedge funds.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments, Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.